Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SH2D3A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PAWR | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ZNF563 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | MAML3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | MGARP | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | FAM72C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | NOC3L | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | ROCK1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CXCL17 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | LARP1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |